The Valley Desk

NCT00055718 · Interventional trial

Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy

Overall registry status Completed

Phase 2

Conditions Drug/Agent Toxicity by Tissue/Organ, Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov